Chicago, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Continuous Bioprocessing market in terms of revenue was estimated to be worth $218 million in 2023 and is poised to reach $599 million by 2028, growing at a CAGR of 22.4% from 2023 to 2028 according to a latest report published by MarketsandMarkets™. The growth of this market is majorly driven by rising focus on rising demand for biopharmaceuticals, growing adoption among CDMOs and CMOs, advantages of continuous bioprocessing over batch/fed-batch mode, among others. The growing demand for biopharmaceuticals is a key growth driver of the continuous bioprocessing market. Biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapi
